Waycross Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,951
Closed -$595K 100
2021
Q2
$595K Hold
2,951
0.32% 63
2021
Q1
$634K Hold
2,951
0.35% 67
2020
Q4
$697K Buy
+2,951
New +$697K 0.43% 54